Antibody-based drugs, which now represent the dominant biologic therapeutic modality, are used to modulate disparate signaling pathways across diverse disease indications. One fundamental premise that has driven this therapeutic antibody revolution is the belief that each monoclonal antibody exhibits exquisitely specific binding to a single-drug target. Herein, we review emerging evidence in antibody off-target binding and relate current key findings to the risk of failure in therapeutic development. We further summarize the current state of understanding of structural mechanisms underpining the different phenomena that may drive polyreactivity and polyspecificity, and highlight current thinking on how de-risking studies may be best implemented in the screening triage. We conclude with a summary of what we believe to be key observations in the field to date, and a call for the wider antibody research community to work together to build the tools needed to maximize our understanding in this nascent area.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726659 | PMC |
| http://dx.doi.org/10.1080/19420862.2021.1999195 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions.
Cell Rep
October 2024
Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:
Article Synopsis
- Antibody variable regions are responsible for binding to specific antigens, but they can also interact non-specifically, affecting the performance of antibody therapeutics in various ways.
- Researchers analyzed over 300,000 antibody sequences to find that the heavy chain mainly determines non-specific interactions due to its properties, such as positive charge and hydrophobicity, which can be assessed using a machine learning model.
- The study identifies key features, particularly those involving tyrosine, that influence both non-specific binding and specific antigen recognition, providing insights for antibody design and understanding molecular immunology.
Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies.
Antib Ther
July 2024
Biotherapeutics and Genetic Medicine, AbbVie Bioresearch Center, Worcester, MA 01605, United States.
Article Synopsis
- Early evaluation of antibody off-target binding is crucial to reduce risks like quick clearance and toxicity, with the baculovirus particle (BVP) binding assay commonly used for this purpose.
- This study introduces a new set of three deep learning models that utilize protein language models to predict outcomes in BVP assays and a complementary bovine serum albumin binding assay.
- The models effectively predicted assay results for various antibody types, marking a significant advancement in computational methods for antibody development.
Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.
MAbs
November 2022
Departments of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA.
Self-association governs the viscosity and solubility of therapeutic antibodies in high-concentration formulations used for subcutaneous delivery, yet it is difficult to reliably identify candidates with low self-association during antibody discovery and early-stage optimization. Here, we report a high-throughput protein engineering method for rapidly identifying antibody candidates with both low self-association and high affinity. We find that conjugating quantum dots to IgGs that strongly self-associate (pH 7.
View Article and Find Full Text PDFHarnessing Antibody Polyspecificity for Cancer Immunotherapy.
Monoclon Antib Immunodiagn Immunother
October 2022
Department of Medicine and Pathology, Winthrop P. Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Targeting the diverse glycan repertoire expressed on tumor cells is considered a viable therapeutic strategy to deal with tumor cell heterogeneity. Inherently polyspecific, natural, glycan-reactive antibodies are purported to be protective in thwarting infections and in cancer immunotherapy. Tumor-associated carbohydrate antigens (TACAs) are related to pathogen glycans, to which nascent or natural antibodies exist and IgM responses are elicited.
View Article and Find Full Text PDFMultiple Sclerosis: Enzymatic Cross Site-Specific Recognition and Hydrolysis of H2A Histone by IgGs against H2A, H1, H2B, H3 Histones, Myelin Basic Protein, and DNA.
Biomedicines
August 2022
Pacific Institute of Bioorganic Chemistry, Far East Division, Russian Academy of Sciences, 690022 Vladivostok, Russia.
Histones have a paramount role in chromatin remodeling and gene transcription. Free histones are damage-associated molecules in the blood; administration of histones to animals drives systemic inflammatory and toxic effects. Myelin basic protein (MBP) is the most crucial component of the axon myelin-proteolipid sheath.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!